Correlation Between NYSE Composite and PsyBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and PsyBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and PsyBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and PsyBio Therapeutics Corp, you can compare the effects of market volatilities on NYSE Composite and PsyBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of PsyBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and PsyBio Therapeutics.
Diversification Opportunities for NYSE Composite and PsyBio Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and PsyBio is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and PsyBio Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PsyBio Therapeutics Corp and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with PsyBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PsyBio Therapeutics Corp has no effect on the direction of NYSE Composite i.e., NYSE Composite and PsyBio Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and PsyBio Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 58.86 times less return on investment than PsyBio Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 106.78 times less risky than PsyBio Therapeutics. It trades about 0.13 of its potential returns per unit of risk. PsyBio Therapeutics Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 0.50 in PsyBio Therapeutics Corp on September 3, 2024 and sell it today you would lose (0.49) from holding PsyBio Therapeutics Corp or give up 98.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 99.56% |
| Values | Daily Returns |
NYSE Composite vs. PsyBio Therapeutics Corp
Performance |
| Timeline |
NYSE Composite and PsyBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
PsyBio Therapeutics Corp
Pair trading matchups for PsyBio Therapeutics
Pair Trading with NYSE Composite and PsyBio Therapeutics
The main advantage of trading using opposite NYSE Composite and PsyBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, PsyBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PsyBio Therapeutics will offset losses from the drop in PsyBio Therapeutics' long position.| NYSE Composite vs. Lindblad Expeditions Holdings | NYSE Composite vs. LB Foster | NYSE Composite vs. HUTCHMED DRC | NYSE Composite vs. Bridgford Foods |
| PsyBio Therapeutics vs. Health Sciences Gr | PsyBio Therapeutics vs. Vg Life Sciences | PsyBio Therapeutics vs. MedMira | PsyBio Therapeutics vs. Oxford Cannabinoid Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |